Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma.

Article Details

Citation

Copy to clipboard

Hood K, Shah A

Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma.

J Adv Pract Oncol. 2016 Mar;7(2):209-218. Epub 2016 Mar 1.

PubMed ID

28090369 [ View in PubMed

]

Abstract

Not Available

DrugBank Data that Cites this Article

Drugs

Belinostat

Drug Targets

Drug	Target	Kind	Organism	Pharmacological Action	Actions
Belinostat	Histone deacetylase (Protein Group)	Protein group	Humans	Yes	Inhibitor	Details